{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T08:20:02Z","timestamp":1795162802541,"version":"4.10.3"},"reference-count":16,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":937,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[1999,6]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>:\u2002Spearmint is commonly used as an antispasmodic and as a flavouring in several medications including antacids. It can produce heartburn, presumably by lowering lower oesophageal sphincter (LES) tone, but the mechanism has not previously been objectively examined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>:\u2002To study the effect of spearmint on LES function, acid reflux and symptoms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>:\u2002In healthy volunteers, a Dent Sleeve and a pH electrode were placed in the distal oesophagus. They were then given spearmint either in a flavouring (0.5\u2003mg), or a high (500\u2003mg) dose, or a placebo, using a double\u2010blind randomized crossover design. LES pressure, oesophageal pH and symptoms were recorded for 30\u2003min before and after administration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>:\u2002LES pressure was not affected by spearmint, either high dose (19.6 vs. 16.0\u2003mmHg), flavouring dose (20.2 vs. 19.8\u2003mmHg) or placebo (20.5 vs. 19.2\u2003mmHg, all N.S.). There were no differences in reflux occurrence following high dose (mean = 0.65 vs. 0.85 episodes), low dose (0.4 vs. 0.5 episodes) or placebo (0.7 vs. 1.10 episodes, all N.S.). There was a significant increase in mean symptom scores following high\u2010dose spearmint (0 vs. 0.35, <jats:italic>P\u2003<\/jats:italic>=\u20030.03), but not low dose (0 vs. 0.2) or placebo (0 vs. 0.5, both N.S.). One subject reported symptoms with placebo, one with low dose, and six with high dose; all without increased reflux episodes or decreased sphincter pressure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>:\u2002Spearmint has no effect on LES pressure or acid reflux. Flavouring doses of spearmint do not produce more symptoms than placebo while high doses can be associated with symptoms, presumably from direct mucosal irritation but not reflux.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.1999.00528.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:38:48Z","timestamp":1047353928000},"page":"805-812","source":"Crossref","is-referenced-by-count":27,"title":["Lack of effect of spearmint on lower oesophageal sphincter function and acid reflux in healthy volunteers"],"prefix":"10.1111","volume":"13","author":[{"given":"R.","family":"Bulat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Fachnie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Tougas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00343.x"},{"key":"e_1_2_6_3_2","unstructured":"Compendium of Pharmaceuticals and Specialties. Canadian Pharmaceutical Association Ottawa Ontario Canada 1998."},{"key":"e_1_2_6_4_2","unstructured":"OrlandoRC.Reflux esophagitis In: Yamada T ed. Textbook of Gastroenterology. Philadelphia: Lippencott 1995."},{"key":"e_1_2_6_5_2","first-page":"39","article-title":"The carminative action of volatile oils","volume":"16","author":"Gunn JWC","year":"1920","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_6_2","first-page":"149","article-title":"Effect of carminative volatile oils on the muscular activity of the stomach and colon","volume":"27","author":"Plant OH","year":"1926","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_7_2","first-page":"A992","article-title":"Inhibitory effect of peppermint oil on gastrointestinal smooth muscle","volume":"24","author":"Taylor BA","year":"1983","journal-title":"Gut"},{"key":"e_1_2_6_8_2","first-page":"A1168","article-title":"Inhibitory effect of peppermint oil and menthol on human isolated coli","volume":"25","author":"Taylor BA","year":"1984","journal-title":"Gut"},{"key":"e_1_2_6_9_2","first-page":"293","article-title":"Calcium antagonist activity of menthol on gastrointestinal smooth muscle","volume":"20","author":"Taylor BA","year":"1985","journal-title":"Br J Clin Pharm"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(86)90223-5"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00584749"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1988.tb00677.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(91)90459-X"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(55)91637-8"},{"key":"e_1_2_6_15_2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0016-5085(69)80061-2","article-title":"F The action of a carminative on the lower esophageal sphincter","volume":"56","author":"Sigmund CJ","year":"1968","journal-title":"Gastroenterology"},{"key":"e_1_2_6_16_2","unstructured":"Martindale; The Extra Pharmacopia. London: Royal Pharmaceutical Society 1996."},{"key":"e_1_2_6_17_2","unstructured":"GillisC WelbanksL BergeronD et\u2003al. Compendium of Pharmaceutical Specialities. 33rdEdition. Bruce LD ed. Ottawa Canada: Canadian Pharmacist Association 1998."}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.1999.00528.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.1999.00528.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.1999.00528.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T01:20:57Z","timestamp":1694395257000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.1999.00528.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,6]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1999,6]]}},"alternative-id":["10.1046\/j.1365-2036.1999.00528.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.1999.00528.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,6]]}}}